CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirota, K.
Right arrow Articles by Lambert, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirota, K.
Right arrow Articles by Lambert, D. G.
Related Collections
Right arrow General Anesthesia
Canadian Journal of Anesthesia 47:467-470 (2000)
© Canadian Anesthesiologists' Society, 2000

Brief Report

Effects of intravenous and local anesthetic agents on {omega}-conotoxin MVIIA binding to rat cerebrocortex

Kazuyoshi Hirota, MD*,{dagger} and David G. Lambert, PhD

* From the University Department of Anaesthesia and Pain Management, Leicester Royal Infirmary,
{dagger} Leicester LE1 5WW, UK, and Department of Anesthesiology University of Hirosaki School of Medicine, Hirosaki, Japan.

Address correspondence to: Dr. D.G. Lambert. Phone: +44-116-258-5291; Fax: +44-116-285-4487; E-mail: DGL3{at}le.ac.uk


    Abstract
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Purpose: The cellular target site(s) for anesthetic action remain controversial. In this study we have examined any interaction of iv anesthetics (thiopental, pentobarbital, ketamine, etomidate, propofol, alphaxalone), local anesthetics (lidocaine, prilocaine, procaine and tetracaine), and the non anesthetic barbiturate, barbituric acid with the {omega}-conotoxin MVIIA binding site on N-type voltage sensitive Ca2+ channels in rat cerebrocortical membranes.

Methods: [125I] {omega}-conotoxin MVIIA binding assays were performed in 0.5 ml volumes of Tris.HCl buffer containing BSA 0.1% for 30 min at 20°C using fresh cerebrocortical membranes (5 µg of protein). Non-specific binding was defined in the presence of excess (10–8 M) {omega}-conotoxin MVIIA. The interaction of iv (alphaxolone, etomidate, propofol, pentobarbitone, ketamine and thiopentone), local (lidocaine, prilocaine, procaine and tetracaine) anesthetics and barbituric acid was determined by displacement of [125I] {omega}-conotoxin MVIIA (~1pM).

Results: The binding of [125I] {omega}-conotoxin was concentration-dependent and saturable with Bmax and Kd of 223 ± 15 fmol/mg protein and 2.13 ± 0.14 pM, respectively. Unlabelled {omega}-conotoxin MVIIA displaced [125I] {omega}-conotoxin MVIIA yielding a pKd of 11.04 ± 0.04 (9.2 pM). All iv and local anesthetics at clinically relevant concentrations did not show any interaction with the {omega}-conotoxin MVIIA binding site.

Conclusion: The present study suggests that {omega}-conotoxin MVIIA binding site on N-type voltage sensitive Ca2+ channels may not be a target for iv and local anesthetic agents.


    Introduction
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
THE role of voltage sensitive Ca2+ channels (VSCC) in anesthesia is controversial.1,2 We have shown that intravenous3 and local4 anesthetics interact with dihydropyridine binding sites on L-type VSCC. Moreover, there was a correlation between anesthetic potency and interaction with the dihydropyridine binding sites.3,4 Despite the observation that central transmission is not usually under the control of L-VSCC these data might implicate L-VSCC as anesthetic target sites.

N-type VSCC are distributed widely in the nervous system and play a far more important role in the control of neurotransmitter release.2 Electrophysiological (functional) studies suggest that clinically relevant concentrations of propofol,5 several barbiturates6 and local anesthetic agents7 significantly depress {omega}-conotoxin sensitive N-channel currents. The precise site of this interaction is unclear.

As part of a broader pharmacological examination of the role of VSCC in anaesthesia (and to allow comparison L-VSCC data) we have examined whether a range of intravenous and local anesthetic agents interact with {omega}-conotoxin binding sites on N-type VSCC. {omega}-Conotoxin VIIA was used as the binding is fully reversible and ideally suited to radioligand binding studies.


    Methods
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Tissue preparation
Female Wistar rats (250-300g) were stunned then decapitated. The brain was rapidly removed, the cerebrocortex detached from its internal structures, placed in 50 mM Tris.HCl, pH7.4 at 4°C, and homogenized using an ultra turrax (T25). The resulting homogenate was centrifuged at 18000 g for 10 min and the pellet resuspended in Tris.HCl buffer. This procedure was repeated three times.

Measurement of [125I] {omega}-conotoxin MVIIA binding.
All binding assays were performed in 0.5 ml volumes of Tris.HCl buffer containing 0.1% bovine serum albumin for 30 min at 20°C using 5 µg fresh membranes. Saturation analyses to determine the equilibrium dissociation constant (Kd) and the maximal binding capacity (Bmax) were performed using increasing concentrations of [125I] {omega}-conotoxin MVIIA (0.1-10 nM). Non-specific binding was defined with 10–8M {omega}-conotoxin MVIIA. Bound and free radioactivity were separated using a Brandell cell harvester onto Whatman GFB filters (treated with 0.1% polyethylenimine) with bound estimated using a {gamma}-counter.

In order to determine if an agent interacted with {omega}-conotoxin binding sites on N-VSCC, these were labeled with a fixed concentration of [125I] {omega}-conotoxin MVIIA. Increasing concentrations of unlabeled displacers (anesthetic agents) were added, and displacement of [125I] {omega}-conotoxin MVIIA binding indicates an interaction at the same site as the radiolabel. [125I] {omega}-conotoxin MVIIA (~1pM) was incubated with various concentrations of the following unlabelled intravenous anesthetic agents: thiopental, pentobarbital, ketamine, etomidate, propofol and alphaxalone, and local anesthetic agents: lidocaine, prilocaine, procaine and tetracaine. A non-anesthetic barbiturate, barbituric acid was also included. Unlabeled {omega}-conotoxin MVIIA was included as a positive control. Agents were dissolved in Tris.HCl buffer from stocks as follows; thiopental (100 mM stock in 0.1M NaOH), pentobarbital and barbituric acid (50 mM stock in distilled water), propofol (100 mM stock in DMSO), alphaxalone (50 mM stock in DMSO), etomidate (50 mM stock in 0.1M HCl), ketamine and local anesthetic agents (500 mM stock in distilled water), and {omega}-conotoxin MVIIA (10-6M in distilled water). Anesthetic concentration used was limited by solubility.

Data analysis
Bmax and Kd were obtained from Scatchard transformation of the specific binding data. The log concentration unlabelled conotoxin producing 50% displacement of labelled conotoxin binding (i.e., isotope dilution), pKd was obtained by computer assisted curve fitting (GraphPad-PRISM). All data are expressed as mean ± SEM, n refers to the number of individual full saturation or displacement curves constructed.


    Results
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The binding of [125I] {omega}-conotoxin was concentration-dependent and saturable with Bmax and Kd of 223 ± 15 fmol•mg-1 protein and 2.13 ± 0.14 pM, respectively. Unlabelled {omega}-conotoxin MVIIA displaced [125I] {omega}-conotoxin MVIIA yielding a pKd of 11.04 ± 0.04 (9.2 pM), in reasonable agreement with the value obtained by direct saturation. These Kd and Bmax values for [125I] {omega}-conotoxin MVIIA binding were similar to those previously reported by Yamada et al.8 More importantly, all anesthetic agents at clinically relevant concentrations failed to displace [125I] {omega}-conotoxin MVIIA (FigureGo).



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE Unlabeled {omega}-conotoxin MVIIA (A) but not Iv (B) or local (C) anesthetic agents at clinically relevant concentrations displaced [125I] {omega}-conotoxin MVIIA binding to N-type voltage sensitive Ca2+ channels. Data are mean ± SEM (n=6) and expressed as displacement where the curves were corrected for the competing mass of [125I] {omega}-conotoxin MVIIA.

 

    Discussion
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
We have failed to detect any interaction between a range of intravenous and local anesthetic agents with the {omega}-conotoxin MVIIA binding site on N-VSCC. These negative findings have important implications in that they cast doubt on the suggestion that N-VSCC may represent a target for, particularly, iv anesthetic agents.

In the search for a common target site for anesthetic agents, voltage and ligand gated ion channels have been extensively studied. It has been suggested that GABAA receptors and voltage sensitive Na+ channels may be the most important target sites for general and local anesthesia, respectively.1,9 However, Ca2+ is also likely to play an important role in the mechanism of general and local anesthesia, as this cation regulates neuronal excitability and neurotransmitter release through VSCC.2

Several reports57 suggest that intravenous and local anesthetics at clinical concentrations inhibit N-VSCC. These data implicate N-VSCC in the mechanism of anesthesia. However, in the present study, clinically relevant concentrations of intravenous and local anesthetic agents did not displace {omega}-conotoxin MVIIA binding to N-VSCC. Nacif-Coelho and colleagues10 failed to report any involvement of N-VSCC in the hypnotic response to dexmedetomidine as the hypnotic effects of this agent were not modified by {omega}-conotoxin MVIIA. However, nifedipine (L-VSCC blocker) and {omega}-conotoxin MVIIC (P+Q-VSCC blocker) produced a loss of righting reflex in the presence of a subhypnotic dose. The clinical significance of these data are difficult to state as this is a mechanistic study. Collectively our data suggest that {omega}-conotoxin MVIIA binding sites on N-VSCC may not be an important anesthetic target. To test this hypothesis in man is not at present feasible as there are currently no N-VSCC blockers available for clinical use.


    Acknowledgments
 
Supported in part by a project grant from the British Journal of Anaesthesia.

Accepted for publication February 4, 2000.


    References
 TOP
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
1 Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 607–14.[Medline]

2 Hirota K, Lambert DG. Voltage sensitive Ca2+ channels and anaesthesia (Editorial). Br J Anaesth 1996; 76: 344–6.[Free Full Text]

3 Hirota K, Lambert DG. I.v. anaesthetic agents inhibit dihydropyridine binding to L-type voltage-sensitive Ca2+ channels in rat cerebrocortical membranes. Br J Anaesth 1996; 77: 248–53.[Abstract/Free Full Text]

4 Hirota K, Browne T, Appadu BL, Lambert DG. Do local anaesthetics interact with dihydropyridine binding sites on neuronal L-type Ca2+ channels? Br J Anaesth 1997; 78: 185–8.[Abstract/Free Full Text]

5 Olcese R, Usai C, Maestrone E, Nobile M. The general anesthetic propofol inhibits transmembrane calcium current in chick sensory neurons. Anesth Analg 1994; 78: 955–60.[Abstract/Free Full Text]

6 Gundersen CB, Umbach JA, Swartz BE. Barbiturates depress currents through human brain calcium channels studies in Xenopus oocytes. J Pharmacol Exp Ther 1988; 247: 824–9.[Abstract/Free Full Text]

7 Sugiyama K, Muteki T. Local anesthetics depress the calcium current of rat sensory neurons in culture. Anesthesiology 1994; 80: 1369–78.[Medline]

8 Yamada S, Uchida S, Ohkura T, et al. Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine. J Pharmacol Exp Ther 1996; 277: 721–7.[Abstract/Free Full Text]

9 Strichartz GR, Berde CB. Local anesthetics. In: Miller RD (Ed.). Anesthesia, 4th ed. New York: Churchill-Livingston, 1994: 489–521.

10 Nacif-Coelho C, Correa-Sales C, Chang LL, Maze M. Perturbation of ion channel conductance alters the hypnotic response to the {alpha}2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat. Anesthesiology 1994; 81: 1527–44.[Medline]




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
S.-W. Ying and P. A. Goldstein
Propofol-Block of SK Channels in Reticular Thalamic Neurons Enhances GABAergic Inhibition in Relay Neurons
J Neurophysiol, April 1, 2005; 93(4): 1935 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P. E. Macintyre
Safety and efficacy of patient-controlled analgesia
Br. J. Anaesth., July 1, 2001; 87(1): 36 - 46.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirota, K.
Right arrow Articles by Lambert, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirota, K.
Right arrow Articles by Lambert, D. G.
Related Collections
Right arrow General Anesthesia


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS